Translational Vision Science & TechnologyDevelopmental BiologyPeer-reviewed journal article
USH2A gene mutations in rabbits lead to progressive retinal degeneration and hearing loss
Van Phuc NguyeniD, Jun Whi SongiD, Diane M. Prieskorn, Junhuang Zou, Yanxiu LiiD, David F. Dolan, Jie XuiD, Jifeng ZhangiD, Thiran JayasunderaiD, Jun YangiD, Yehoash RaphaeliD, Naheed Wali KhaniD, Michael Iannuzzi, Charles L. Bisgaier, Y. Eugene CheniD, Yannis Mantas PaulusiD, Dongshan YangiD
Abstract
Mutations in USH2A gene are responsible for the greatest proportion of hearing and vision loss among individuals with Usher Syndrome (USH) and for autosomal recessive non-syndromic retinitis pigmentosa. Mutations on USH2A exon 13 account for more than 35% of the disease causing USH2A variants including the most prevalence point mutation, c.2299delG, a frameshift mutation. The lack of a clinically relevant animal model has been a bottleneck for the development of therapeutics for USH2A related vision loss. Using CRSPR/Cas9 technology, this study establishes a rabbit line carrying an USH2A frameshift mutation on exon12 (equivalent to human USH2A Exon 13) as a novel mammalian animal model of USH2A. The bi-allelic mutant rabbits exhibit hyper reflective signals in FAF indicating RPE damage and OCT changes indicating photoreceptor degeneration as early as 4 months of age. ERG signals of both rod and cone function were reduced in the USH2A mutant rabbits starting from 7 months old and further decreased at 15-22 months old, indicating progressive retinal photoreceptor degeneration, which is further confirmed by retinal histopathology examination. ABR examination showed moderate to server hearing loss in the USH2A mutant rabbits. These results indicated that disruption of USH2A gene in rabbits is sufficient to induce hearing loss and progressive photoreceptor degeneration. To our knowledge, this is the first mammalian animal model of USH2 which closely recapitulates the phenotype of retinitis pigmentosa in human patients. This study supports the use of rabbits as a clinically relevant animal model to understand the pathogenesis and to develop novel therapeutics for Usher Syndrome.
- Citations
- 16
- FWCI
- 1.42
- Field percentile
- top 20%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Early Disruption of Photoreceptor Cell Architecture and Loss of Vision in a Humanized Pig Model of Usher Syndrome
Sophia Grotz, Jessica Schäfer, … Nikolai Klymiuk·EMBO Molecular MedicinePeer-reviewed·Mar 7, 2022
- Exon 13-skipped USH2A protein retains functional integrity in mice, suggesting an exon skipping therapeutic approach to treat USH2A-associated disease.
Nachiket D. Pendse, Verónica Lamas, … Qin Liu·bioRxiv·Feb 4, 2020
- Potential therapy for progressive vision loss due to PCDH15-associated Usher syndrome developed in an orthologous Usher mouse
Saumil Sethna, Wadih M. Zein, … Zubair M. Ahmed·bioRxiv·Jun 8, 2021
- Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations
Kalyan Dulla, Ralph W. N. Slijkerman, … Erwin van Wijk·Molecular TherapyPeer-reviewed·Apr 23, 2021
- Preclinical Development and Safety of Laterally Spreading Dual AAV.SPR-MYO7A Vectors for the Treatment of Usher Syndrome Type 1B
Kaitlyn R. Calabro, Eva Andrés‐Mateos, … Shannon E. Boye·bioRxiv·Oct 29, 2026
- Hexafluoro slows retinal degeneration and improves visual function in zebrafish models of Usher syndrome 1F
Jennifer B. Phillips, Siena Kulis, … Monte Westerfield·bioRxiv·Dec 29, 2023